Related Experiment Video
Updated: May 10, 2026

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Linear energy transfer-guided optimization in intensity modulated proton therapy: feasibility study and clinical
Drosoula Giantsoudi1, Clemens Grassberger, David Craft
1Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts, USA. dgiantsoudi@partners.org
Summary
This study shows that optimizing proton therapy using linear energy transfer (LET) can significantly improve treatment plans. Guiding optimization with LET distributions allows for better tumor targeting and normal tissue sparing, potentially enhancing clinical benefits.
Area of Science:
- Medical Physics
- Radiation Oncology
- Computational Biology
Background:
- Intensity modulated proton therapy (IMPT) offers precise dose delivery.
- Optimizing IMPT plans traditionally focuses on physical dose distributions.
- Linear energy transfer (LET) variations can significantly impact biological outcomes.
Purpose of the Study:
- To assess the feasibility of using LET-guided optimization in IMPT.
- To explore the potential clinical benefits of LET-guided IMPT plan optimization.
- To investigate the impact of LET variations on dose and biological effectiveness.
Main Methods:
- Generated Pareto-optimal IMPT base plans (BPs) using multicriteria optimization (MCO) for head-and-neck and pancreatic cancer patients.
- Calculated dose and LET distributions using a Monte Carlo platform.
- Utilized an MCO navigation module for interpolating between BPs and an LET-based relative biological effectiveness (RBE) model.
Main Results:
- Significant variations in mean LET (up to 30% in targets, up to 2x in organs at risk) were observed among BPs.
- An inverse relationship between dose and LET in organs at risk was typically found.
- LET-guided navigation showed potential for up to 40% improvement in RBE-weighted dose.
Conclusions:
- LET variations in IMPT base plans can lead to substantial differences in RBE-weighted doses.
- A novel strategy for optimizing proton therapy maximizes tumor LET while minimizing normal tissue LET.
- Pareto-surface navigation using dose and LET distributions aids in identifying clinically optimal IMPT plans.

